Cheng Liu - Estrella Immunopharma President CEO
| ESLA Stock | 1.14 0.10 9.62% |
CEO
Cheng Liu is President CEO of Estrella Immunopharma
| Age | 57 |
| Address | 5858 Horton Street, EmeryVille, CA, United States, 94608 |
| Phone | 510 318 9098 |
| Web | https://www.estrellabio.com |
Estrella Immunopharma Management Efficiency
The company has return on total asset (ROA) of (1.2212) % which means that it has lost $1.2212 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (2.7812) %, meaning that it created substantial loss on money invested by shareholders. Estrella Immunopharma's management efficiency ratios could be used to measure how well Estrella Immunopharma manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to -0.1. The current year's Return On Capital Employed is expected to grow to -0.18. At present, Estrella Immunopharma's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Assets is expected to grow to about 333.5 K, whereas Non Current Assets Total are forecasted to decline to 0.00.Similar Executives
| Found 8 records | CEO Age | ||
| David Lesar | CenterPoint Energy | 67 | |
| Carlos Brito | Anheuser Busch Inbev | 60 | |
| Brendan Whitworth | Anheuser Busch Inbev | 45 | |
| John Akers | Atmos Energy | 61 | |
| Jason CPA | CenterPoint Energy | 46 | |
| David Burwick | Boston Beer | 62 | |
| John Somerhalder | CenterPoint Energy | 63 | |
| Jean Neto | Ambev SA ADR | 50 | |
Management Performance
| Return On Equity | -2.78 | ||||
| Return On Asset | -1.22 |
Estrella Immunopharma Leadership Team
Elected by the shareholders, the Estrella Immunopharma's board of directors comprises two types of representatives: Estrella Immunopharma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Estrella. The board's role is to monitor Estrella Immunopharma's management team and ensure that shareholders' interests are well served. Estrella Immunopharma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Estrella Immunopharma's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Cheng Liu, President CEO | ||
| Jiandong Xu, Chief Officer |
Estrella Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Estrella Immunopharma a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -2.78 | ||||
| Return On Asset | -1.22 | ||||
| Current Valuation | 19.23 M | ||||
| Shares Outstanding | 36.18 M | ||||
| Shares Owned By Insiders | 72.06 % | ||||
| Shares Owned By Institutions | 0.55 % | ||||
| Number Of Shares Shorted | 14.56 K | ||||
| Price To Book | 55.02 X | ||||
| EBITDA | (1.57 M) | ||||
| Net Income | (7.31 M) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Estrella Immunopharma is a strong investment it is important to analyze Estrella Immunopharma's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Estrella Immunopharma's future performance. For an informed investment choice regarding Estrella Stock, refer to the following important reports:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Estrella Immunopharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. For information on how to trade Estrella Stock refer to our How to Trade Estrella Stock guide.You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Estrella Immunopharma. If investors know Estrella will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Estrella Immunopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.24) | Return On Assets (1.22) | Return On Equity (2.78) |
The market value of Estrella Immunopharma is measured differently than its book value, which is the value of Estrella that is recorded on the company's balance sheet. Investors also form their own opinion of Estrella Immunopharma's value that differs from its market value or its book value, called intrinsic value, which is Estrella Immunopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Estrella Immunopharma's market value can be influenced by many factors that don't directly affect Estrella Immunopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Estrella Immunopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Estrella Immunopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Estrella Immunopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.